Ryan Allway March 7th, 2023 News, Top Story The global CBD industry is expected to grow from less than $10 billion in 2022 to more than $136 billion by 2030, according to Contrive Datum Insights, representing a blistering 38.9% compound annual growth rate over the forecast period. After securing... Read more
Ryan Allway February 21st, 2023 News, Top Story 1606 Corp. (OTC: CBDW), an acquirer and developer of CBD brands, including Truz and CBD Singlez, recently announced a $20 million equity financing agreement with GHS Investments LLC to build out its business with additional brands, distribution networks, and businesses. Following... Read more
Ryan Allway February 14th, 2023 News, Top News, Top Story POTOMAC, Md., Feb. 14, 2023 (GLOBE NEWSWIRE) — via InvestorWire — India Globalization Capital, Inc. (dba IGC, Inc.) (NYSE American: IGC) (“IGC” or the “Company”) today reported its third fiscal quarter 2023 financial results. Third Fiscal Quarter 2023 Highlights:... Read more
Kaya Holdings, Inc. (OTCQB:KAYS) Launches Fifth Dimension Therapeutics(TM) to seek to Provide Innovative Psychedelic-Based Treatments for Depression and Anxiety Related Conditions and address the Growing Multi-Billion Dollar Global Psychedelics Market
Oregon January 25, 2023
Ryan Allway January 25th, 2023 Psychedelics, Top Story FT. LAUDERDALE, FL / ACCESSWIRE / January 25, 2023 / Kaya Holdings, Inc., (“KAYS” or the “Company”) (OTCQB:KAYS), a pioneer in the U.S. cannabis industry, announced today that it has launched Fifth Dimension Therapeutics™ (“FDT”), which will seek to provide psychedelic “mind... Read more
Israel-Based Clearmind Successfully Completed Two R&D Projects With The Hebrew University of Jerusalem’s Tech Transfer Company, Yissum
January 19, 2023
Ryan Allway January 19th, 2023 Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “Company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the successful completion of two R&D projects with leading scientists from multiple... Read more
Israel-Based Clearmind Medicine Shows Efficacy of Psychedelic- Derived Obesity Treatment in Pre-Clinical Trial
January 5, 2023
Ryan Allway January 5th, 2023 News, Top Story Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “Company“), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, today announced positive pre-clinical results demonstrating efficacy of its drug candidate... Read more
Israeli Cannabis Technology Company BYND Cannasoft Enterprises Inc. Files EZ-G Patent Application to Include Double Faceted Condom
December 1, 2022
Ryan Allway December 1st, 2022 News, Top Story BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”) announced today the filing of a patent application for its EZ-G device to include an innovative double-faceted condom design. The double-faceted condom is designed to help treat various problems related to... Read more
BioHarvest Opens the Door for Pharma Researchers to Unlock the Power of Cannabinoids
November 23, 2022
Ryan Allway November 23rd, 2022 The medical cannabis industry will reach more than $54 billion in size by 2029, according to Data Bridge Market Research, representing a 22.1% compound annual growth rate. In addition to patients turning to state medical cannabis programs, researchers continue to uncover evidence that cannabinoids... Read more
Ryan Allway November 14th, 2022 News, Top Story JACKSONVILLE, FL / ACCESSWIRE / November 14, 2022 / LFTD Partners Inc. (“LFTD Partners” or the “Company”) (OTCQB:LIFD), the corporate parent of leading cannabis and psychedelics manufacturer Lifted Made, today reported that it achieved its ninth consecutive quarter of positive earnings per share during the... Read more
BioHarvest Introduces a Breakthrough Technology That Dramatically Improves Cannabis Industry Economics
November 3, 2022
Ryan Allway November 3rd, 2022 BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: VNVCF) is well-known for its ability to scale up trace botanical elements. For example, its flagship VINIA capsules contain the same amount of piceid resveratrol as an entire bottle of red wine with no calories, sugar, or alcohol.... Read more
